Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

v3.21.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Revenues $ 0 $ 0
Operating expenses:    
Research and development 4,105 3,206
General and administrative 1,939 1,810
Depreciation and amortization 44 46
Total operating expenses 6,088 5,062
Loss from operations (6,088) (5,062)
Other income:    
Gain from change in fair value of warrant liability 1,577 3,845
Other income, net 9 5
Interest income, net 57 3
Net loss $ (4,445) $ (1,209)
Net loss per common share - basic and diluted (in dollars per share) $ (0.20) $ (0.15)
Weighted average common shares outstanding, basic and diluted (in shares) 21,808,565 8,321,833
Net loss $ (4,445) $ (1,209)
Other comprehensive income (loss):    
Foreign currency translation (4) (33)
Comprehensive loss $ (4,449) $ (1,242)